Studies of fetal remains by array CGH. 50% of miscarriages in the first trimester of pregnancy are due to chromosomal abnormalities. The array CGH is a molecular technique that allows direct analysis of aneuploidy for chromosomes 24. The study of markers in maternal blood can rule out misdiagnosis for possible maternal contamination.
Results in a week, 98.6% accuracy, does not require cultivation. Higher resolution than that obtained in the conventional karyotype
To assess the status of women endometrial receptivity to prevent implantation failure.
It is a diagnostic method, developed by IREG that identifies the window of implantation and result set based on a transfer of personal embiones. 24% of patients are unreceptive, in 88% of these cases, a 2nd bipsia determine the window of implantation and therefore, the period in which the patient is receptive. Indicated in women with implantation failure with good quality embryos.
Test or male infertility Sperm Aneuploidy (SAT) is a diagnostic test for the study of male infertildad. In couples where a male factor underlying the risk of transmitting chromosome to the offspring of sperm abnormalities procentes increases.
Assesses the presence of alterations in the number of chromosomes (aneuploidy and diploidías) in sperm. Aid partner counseling before assisted reproductive treatment.
40,000 study DNA variants associated with over 600 diseases. To determine the risk of having a child with a genetic disease by analyzing DNA variants 40,000 and more than 600 genetic diseases.
Possibility of offering patients a test to infertility clinics receiving a donation of sperm or eggs. The most common monogenic diseases such as cystic fibrosis, spinal muscular atrophy, X-Fragil Beta thalassemia, etc.